BioSpace News Archive

Press Releases

MaaT Pharma Announces Positive Second DSMB Review of Ongoing Phase 2b Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT

January 21, 2025
·
4 min read
Press Releases

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

January 21, 2025
·
1 min read
Press Releases

ALX Oncology to Host Virtual Company Event Highlighting Updated Data from ASPEN-06 Phase 2 Trial Presented at 2025 ASCO GI

January 21, 2025
·
2 min read
Press Releases

Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

January 21, 2025
·
13 min read
Press Releases

Natera to Present New Data at the 2025 ASCO GI Symposium

January 21, 2025
·
8 min read
Press Releases

Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer

January 21, 2025
·
7 min read
Press Releases

Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

January 21, 2025
·
7 min read
Press Releases

Adagene to Announce Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer at ASCO Gastrointestinal Cancers Symposium

January 21, 2025
·
5 min read
Press Releases

Arcus Biosciences Appoints Richard Markus, M.D., Ph.D. as Chief Medical Officer

January 21, 2025
·
8 min read
Press Releases

CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025

January 21, 2025
·
1 min read